Breaking News Instant updates and real-time market news.

CBS

CBS

, LGF.A

Lionsgate

$24.86

0.17 (0.69%)

07:22
05/19/17
05/19
07:22
05/19/17
07:22

CBS is predator and prey,' says RBC Capital

As the situation deteriorates for media companies due to accelerating cord cutting and weak ad trends, RBC Capital analyst Steven Cahall thinks that companies in the sector will look to consolidate.He believes that CBS (CBS) could buy Lionsgate (LGF.A,LGF.B) in a deal that would be 5% accretive and be viewed favorably by the market or the TV network could be acquired by Verizon (VZ). However, the analyst thinks the most likely scenario is an acquisition of Viacom (VIAB) by CBS.

CBS

CBS

LGF.A

Lionsgate

$24.86

0.17 (0.69%)

LGF.B

Lionsgate

$22.72

0.12 (0.53%)

VZ

Verizon

$45.04

0.56 (1.26%)

VIAB

Viacom

$33.99

0.34 (1.01%)

  • 19

    May

  • 25

    May

  • 01

    Jun

  • 15

    Jun

  • 27

    Jun

CBS CBS

04/27/17
WEDB
04/27/17
NO CHANGE
WEDB
CBS valuation 'largely compensates' for strike risk, says Wedbush
Wedbush analyst James Dix says that CBS' ratings and revenue could be adversely affected if a threatened writers' strike materializes. However, the analyst says that the stock's valuation "largely compensates" for this risk. His 2017 and 2018 estimates for the company, which assume a strike does not occur, are above consensus levels. He keeps a $77 price target and an Outperform rating on the shares.
04/04/17
RSBL
04/04/17
INITIATION
Target $80
RSBL
Buy
CBS initiated with a Buy at Rosenblatt
Rosenblatt started CBS with a Buy rating and $80 price target.
05/15/17
LOOP
05/15/17
NO CHANGE
Target $76
LOOP
Buy
CBS in 'enviable position' ahead of upfront presentation, says Loop Capital
Loop Capital analyst David Miller noted that CBS will finish as the number one network in total viewers for the fourteenth time in fifteen years when the 2016-2017 broadcast season ends this month and that the company's flagship network has no "glaring weakness" within any day or day-part. This makes CBS the one broadcast or cable network that has real leverage over media buyers as "upfront" negotiations begin next week, said Miller, who keeps a Buy rating and $76 price target on CBS shares.
04/28/17
NEED
04/28/17
NO CHANGE
Target $80
NEED
Buy
CBS price target raised to $80 from $72 at Needham
Needham analyst Laura Martin raised her price target for CBS to $80 from $72 based on higher revenue and EPS estimates in 2018 tied to higher expectations in the Local Broadcasting division which should benefit from higher political revenue and profitability. The analyst reiterates a Buy rating on the shares.
LGF.A Lionsgate
$24.86

0.17 (0.69%)

04/04/17
ADAM
04/04/17
INITIATION
Target $30
ADAM
Buy
Lionsgate initiated with a Buy at Canaccord
Canaccord analyst Sharath Toopran initiated Lionsgate with a Buy rating citing its track record of delivering successful motion picture franchises and platform-defining television content. He believes the company is well positioned to leverage some of the primary industry trends, including a rising demand for video content, new digital platforms, and a robust premium television market. Toopran has a $30 price target on Lionsgate shares.
05/19/17
RBCM
05/19/17
NO CHANGE
RBCM
Discovery likely to make deal, says RBC Capital
As the situation deteriorates for media companies due to accelerating cord cutting and weak ad trends, RBC Capital analyst Steven Cahall thinks that companies in the sector will look to consolidate. He thinks that Discovery (DISCA) will likely look to combine with either Lionsgate (LGF.A,LGF.B) or Charter (CHTR) and could look to combine with Scripps Networks (SNI).
04/04/17
RSBL
04/04/17
INITIATION
Target $32
RSBL
Buy
Lionsgate initiated with a Buy at Rosenblatt
Rosenblatt started Lionsgate with a Buy rating and $32 price target.
04/04/17
04/04/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Snap (SNAP) initiated with a Neutral due to valuation at BTIG. 2. HP Enterprise (HPE) initiated with a Hold at Berenberg. 3. Hasbro (HAS) initiated with a Neutral at B. Riley. 4. Lionsgate (LGF.A, LGF.B) initiated with a Buy at Canaccord. 5. Vistra Energy (VSTE) initiated with a Peer Perform at Wolfe Research. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LGF.B Lionsgate
$22.72

0.12 (0.53%)

VZ Verizon
$45.04

0.56 (1.26%)

05/03/17
05/03/17
DOWNGRADE

Hold
Wunderlich downgrades Charter on valuation, sees some level of M&A priced in
As previously reported, Wunderlich analyst Matthew Harrigan downgraded Charter (CHTR) to Hold from Buy, citing valuation. He thinks that the current stock price imbeds some expectation for merger activity, apart from an eventual collapse of the Liberty Broadband (LBRDA) and Liberty Ventures (LVNTA) ownership structure, he tells investors. While a theoretical merger with Verizon (VZ) is "at least as strategically compelling" as AT&T's (T) deal for Time Warner (TWX), Harrigan thinks that price and regulatory hurdles could be difficult to overcome. He cut his price target on Charter to $350 from $360.
04/24/17
OPCO
04/24/17
NO CHANGE
OPCO
Sprint, DISH the only assets for sale, says Oppenheimer
Oppenheimer analyst Timothy Horan noted that wireless companies will be allowed to discuss M&A, and says he sees Sprint (S) and possibly DISH (DISH) as the only assets for sale. The analyst believes the most likely outcome is for consolidation around the four major wireless providers, something along the lines of Charter (CHTR)/Sprint, T-Mobile (TMUS)/Comcast (CMCSA; CMCSK), Verizon (VZ)/DISH, with AT&T's (T) position "fairly solidified" with DirectTV/Time Warner (TWX). Further, Horan suspects Sprint will be sold first, most likely to Charter, although T-Mobile is a possibility and could be the controlling company/management and likely paying a premium for Sprint.
04/26/17
UBSW
04/26/17
NO CHANGE
Target $29
UBSW
Neutral
Corning doing better than expected, says UBS
UBS analyst Tejas Venkatesh noted Corning (GLW) beat expectations for Q1 and its guidance surpassed expectations, leading him to say the company is doing better than expected. He also believes the company's deal with Verizon (VZ) is significant, though he maintains his Neutral rating on Corning shares due to currency risk that keeps him on the sidelines. Venkatesh raised his price target to $28.50 from $26 on Corning.
05/02/17
OPCO
05/02/17
NO CHANGE
Target $472
OPCO
Outperform
Equinix price target raised to $472 from $440 at Oppenheimer
Oppenheimer analyst Timothy Horan raised his price target for Equinix (EQIX) to $472 from $440 after the company closed its acquisition of Verizon's (VZ) 29 data centers. The analyst sees upside from continued strong neutral datacenter demand with Verizon adding to Equinix's densely connected footprint, but also expanding its enterprise channel. He reiterates an Outperform rating on Equinix's shares.
VIAB Viacom
$33.99

0.34 (1.01%)

05/10/17
DBAB
05/10/17
DOWNGRADE
Target $32
DBAB
Sell
Viacom downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Bryan Kraft downgraded Viacom (VIAB) to Sell after learning Charter (CHTR) re-tiered the company's most popular networks to its TV Gold package, its most expensive video tier, and into its Digi Tier. The analyst expects this to dive more revenue pressure at Viacom and cut his price target for the shares to $32 from $35.
05/05/17
MSCO
05/05/17
NO CHANGE
Target $48
MSCO
Overweight
Viacom fears priced in, opportunities ahead, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne said Viacom shares are pricing in fears of a major distribution loss, which is unlikely, and said a 13% free cash flow yield on a growing business medium-term is compelling. The analyst continues to expects US distribution revenue growth to accelerate as it reprices from AT&T/DirecTV, and expects ad revenue to stabilize towards +50bps annual growth by 2018. Swinburne rates Viacom an Overweight with a $48 price target.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $55
FBCO
Outperform
Viacom price target raised to $55 from $50 at Credit Suisse
Credit Suisse analyst Omar Sheikh raised his price target for Viacom to $55 from $50, arguing that the company will be the "biggest beneficiary" amongst peers of targeted linear TV advertising in the U.S., which can drive an acceleration in industry ad growth long-term. The analyst reiterates an Outperform rating on the shares.
05/02/17
MSCO
05/02/17
NO CHANGE
Target $52
MSCO
Overweight
Viacom risk/reward remains compelling, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne continues to view Viacom's risk/reward as compelling as he expects cable networks to benefit from repricing actions in CY16, and for sub losses not to worsen. Swinburne also said Viacom shares do not capture the value of Paramount and new management is focused more on costs than the prior team. The analyst rates Viacom an Overweight with a $52 price target.

TODAY'S FREE FLY STORIES

ROKU

Roku

$21.87

-0.16 (-0.73%)

07:25
10/23/17
10/23
07:25
10/23/17
07:25
Initiation
Roku initiated  »

Roku initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TSRO

Tesaro

$116.40

0.89 (0.77%)

, CLVS

Clovis

$77.50

0.73 (0.95%)

07:24
10/23/17
10/23
07:24
10/23/17
07:24
Initiation
Tesaro, Clovis initiated  »

Tesaro initiated with an…

TSRO

Tesaro

$116.40

0.89 (0.77%)

CLVS

Clovis

$77.50

0.73 (0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 06

    Nov

  • 08

    Nov

NCNA

NuCana

$14.08

-0.3 (-2.09%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Initiation
NuCana initiated  »

NuCana initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:23
10/23/17
10/23
07:23
10/23/17
07:23
General news
Futures higher ahead of buy week of earnings »

Stock futures are…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Aimmune, DBV Technologies analyst commentary  »

Aimmune price target…

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FL

Foot Locker

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Downgrade
Foot Locker rating change  »

Foot Locker downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$95.18

1.73 (1.85%)

07:23
10/23/17
10/23
07:23
10/23/17
07:23
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

JPM

JPMorgan

$99.51

1.4 (1.43%)

07:22
10/23/17
10/23
07:22
10/23/17
07:22
Periodicals
JPMorgan, Mosaic Smart Data partner to boost fixed-income trading, Reuters says »

JPMorgan has teamed up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 02

    Nov

  • 05

    Nov

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

CLVS

Clovis

$77.50

0.73 (0.95%)

07:21
10/23/17
10/23
07:21
10/23/17
07:21
Initiation
Clovis initiated  »

Clovis initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BIIB

Biogen

$338.10

-4.32 (-1.26%)

, ESALY

Eisai

$53.38

-0.25 (-0.47%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Hot Stocks
Biogen, Eisai expand existing collaboration agreement »

Eisai Co., Ltd. (ESALY)…

BIIB

Biogen

$338.10

-4.32 (-1.26%)

ESALY

Eisai

$53.38

-0.25 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

NITE

Nightstar Therapeutics

$19.00

-0.1 (-0.52%)

07:19
10/23/17
10/23
07:19
10/23/17
07:19
Initiation
Nightstar Therapeutics initiated  »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Earnings
Potlatch reports Q3 EPS ex-items 94c, consensus 90c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

PCH

Potlatch

$53.00

-0.35 (-0.66%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Hot Stocks
Potlatch raises dividend to 40c per share from 37.5c per share »

Potlatch announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SAIC

SAIC

$70.88

1.04 (1.49%)

07:18
10/23/17
10/23
07:18
10/23/17
07:18
Upgrade
SAIC rating change  »

SAIC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

GGB

Gerdau

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Gerdau initiated  »

Gerdau resumed with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALE

Vale

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Vale initiated  »

Vale resumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCCO

Southern Copper

$43.13

-0.16 (-0.37%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Southern Copper initiated  »

Southern Copper resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBR

Fibria Celulose

$16.24

0.45 (2.85%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Initiation
Fibria Celulose initiated  »

Fibria Celulose resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCH

Potlatch

$53.00

-0.35 (-0.66%)

, DEL

Deltic Timber

$89.12

0.98 (1.11%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Hot Stocks
Mike Covey to continue to serve as chairman and CEO of combined Potlatch, Deltic »

The leadership team will…

PCH

Potlatch

$53.00

-0.35 (-0.66%)

DEL

Deltic Timber

$89.12

0.98 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 02

    Nov

GOOG

Alphabet

$988.20

3.75 (0.38%)

, GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

07:17
10/23/17
10/23
07:17
10/23/17
07:17
Periodicals
Google plans to share revenues with news publishers, FT reports »

Google is planning to…

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

BIIB

Biogen

$338.10

-4.32 (-1.26%)

07:16
10/23/17
10/23
07:16
10/23/17
07:16
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

PCH

Potlatch

$53.00

-0.35 (-0.66%)

, DEL

Deltic Timber

$89.12

0.98 (1.11%)

07:15
10/23/17
10/23
07:15
10/23/17
07:15
Hot Stocks
Potlatch, Deltic Timber to combine in all-stock transaction »

Potlatch Corporation…

PCH

Potlatch

$53.00

-0.35 (-0.66%)

DEL

Deltic Timber

$89.12

0.98 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 02

    Nov

PSTI

Pluristem

$1.77

-0.035 (-1.94%)

07:15
10/23/17
10/23
07:15
10/23/17
07:15
Hot Stocks
Pluristem receives European patent covering PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
10/23/17
10/23
07:15
10/23/17
07:15
General news
FX Update: The dollar traded firmer »

FX Update: The dollar…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

07:14
10/23/17
10/23
07:14
10/23/17
07:14
Hot Stocks
Halliburton CEO says 'North American business is hitting on all cylinders' »

"We had a strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.